See also this year's filing and all EDGAR filings for this company.
PDF Report 0001346302_2021_XERIS_PHARMACEUTICALS_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Liabilities', 'missing_ratio': 0.055817987386431574, 'aggregate_val': 125390000, 'exp_sum': 118761000, 'exp_to_value': {'LiabilitiesCurrent': 28207000, 'LiabilitiesNoncurrent': 0, 'remainder_Liabilities': 90554000}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001346302')"} |
Graph
Absolute values for 0001346302, XERIS PHARMACEUTICALS INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 152,212,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 6,707,000 |
| 3 | remainder_Assets | 232,000 |
| 4 | LiabilitiesCurrent | 28,207,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 97,183,000 |
| 7 | CostOfGoodsAndServicesSold | 9,328,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 73,732,000 |
| 9 | ResearchAndDevelopmentExpense | 20,921,000 |
| 10 | remainder_Expenses | -110,000 |
| 11 | remainder_Revenues | 20,155,000 |
| 12 | remainder_NetIncome | -7,424,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 159,151,000 |
| 1 | Liabilities | 125,390,000 |
| 2 | Expenses | 103,871,000 |
| 3 | Revenues | 20,155,000 |
| 4 | StockholdersEquity | 33,761,000 |
| 5 | NetIncome | -91,140,000 |
| 6 | ComprehensiveNetIncome | -91,140,000 |
| 7 | BaseVar | 207,995,500 |
| 8 | EconomicCapitalRatio | -0.232 |
Edgar->Model Mapping
Feature Distribution
Change over Time
